Related Experiment Videos
Injection snoreplasty: extended follow-up and new objective data
Scott E Brietzke1, Eric A Mair
1Department of Otolaryngology-Head and Neck Surgery, Walter Reed Army Medical Center, Washington, DC, USA.
Summary
Injection snoreplasty offers a minimally invasive option for primary snoring. While long-term subjective success is 75%, objective data show reduced palatal flutter and loudness, suggesting its effectiveness.
Area of Science:
- Otolaryngology
- Sleep Medicine
- Minimally Invasive Procedures
Background:
- Primary snoring is a common condition often treated with various interventions.
- Injection snoreplasty is a recently developed, minimally invasive treatment option.
Purpose of the Study:
- To evaluate the extended follow-up subjective outcomes of injection snoreplasty.
- To present objective pre- and post-treatment data from a new cohort of patients.
Main Methods:
- Initial cohort (n=25) surveyed at 19 months for snoring level, discomfort, and satisfaction.
- New cohort (n=17) with primary snoring underwent objective snoring measurement (acoustical analysis) before and after injection snoreplasty.
Main Results:
- Subjective success decreased from 92% to 75% at 19-month follow-up, with an 18% relapse rate.
- Objective analysis showed significant reductions in palatal flutter and snoring loudness.
- Pretreatment measurements strongly correlated with treatment success.
Conclusions:
- Injection snoreplasty's success and relapse rates are comparable to other snoring treatments.
- Objective data confirm the procedure's efficacy in reducing palatal flutter snoring.
- Preprocedure snoring analysis may predict treatment response for palatal stiffening therapies.